Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 9;13(4):974.
doi: 10.3390/life13040974.

Advances in Early Detection of Melanoma and the Future of At-Home Testing

Zachary R Garrison  1 , Connor M Hall  1 , Rosalyn M Fey  1 , Terri Clister  1 , Nabeela Khan  1 , Rebecca Nichols  1 , Rajan P Kulkarni  1   2   3   4
Affiliations
Review

Advances in Early Detection of Melanoma and the Future of At-Home Testing

Zachary R Garrison et al. Life (Basel). .

Abstract

The past decade has seen numerous advancements in approaches to melanoma detection, each with the common goal to stem the growing incidence of melanoma and its mortality rate. These advancements, while well documented to increase early melanoma detection, have also garnered considerable criticism of their efficacy for improving survival rates. In this review, we discuss the current state of such early detection approaches that do not require direct dermatologist intervention. Our findings suggest that a number of at-home and non-specialist methods exist with high accuracy for detecting melanoma, albeit with a few notable concerns worth further investigation. Additionally, research continues to find new approaches using artificial intelligence which have promise for the future.

Keywords: artificial intelligence; early-detection; melanoma; primary-care; self-screening.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Saginala K., Barsouk A., Aluru J.S., Rawla P., Barsouk A. Epidemiology of Melanoma. Med. Sci. 2021;9:63. doi: 10.3390/medsci9040063. - DOI - PMC - PubMed
    1. Carr S., Smith C., Wernberg J. Epidemiology and risk factors of melanoma. Surg. Clin. N. Am. 2020;100:1–12. doi: 10.1016/j.suc.2019.09.005. - DOI - PubMed
    1. Tripp M.K., Watson M., Balk S.J., Swetter S.M., Gershenwald J.E. State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now. CA Cancer J. Clin. 2016;66:460–480. doi: 10.3322/caac.21352. - DOI - PMC - PubMed
    1. Pennie M.L., Soon S.L., Risser J.B., Veledar E., Culler S., Chen S.C. Melanoma outcomes for Medicare patients: Association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch. Derm. 2007;143:488–494. doi: 10.1001/archderm.143.4.488. - DOI - PubMed
    1. Datzmann T., Schoffer O., Meier F., Seidler A., Schmitt J. Are patients benefiting from participation in the German skin cancer screening programme? A large cohort study based on administrative data. Br. J. Derm. 2022;186:69–77. doi: 10.1111/bjd.20658. - DOI - PubMed

LinkOut - more resources